Colorectal cancer prevention in Europe: burden of disease and status of screening programs.

Colorectal cancer is a major public health challenge worldwide. In Europe it is the first malignancy in terms of incidence and the second in terms of mortality in both genders. Despite evidence indicating that removal of premalignant and early-stage cancer lesion scan greatly reduce mortality, remarkable differences are still found among countries both in terms of organized screening programs and of the tests used. In 2003 the European Council recommended that priority be given to activation of organized cancer screening programs, and various states have been making significant efforts to adopt effective prevention programs with international quality standards and centralizing screening organization and result evaluation. After a 2008 European Union report on the state of screening program, activation highlighted that little more than 50% (12/22) of Member States had colorectal cancer screening programs, Screening programs have been adopted or earlier pilot projects have been extended nationwide. This paper examines the state of activation and the screening strategies of colorectal cancer screening programs in EU States as of July 2013.

[1]  K. Brasso,et al.  Determinants of participation in colorectal cancer screening with faecal occult blood testing. , 2010, Journal of public health.

[2]  C. Dimitrakaki,et al.  Use of cancer screening services in Greece and associated social factors: results from the nation-wide Hellas Health I survey , 2009, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[3]  B. Denis,et al.  Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial). , 2009, European journal of cancer.

[4]  J. Habbema,et al.  Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels , 2009, British Journal of Cancer.

[5]  G. Ioannou,et al.  Predictors of colorectal cancer screening participation in the United States , 2003, American Journal of Gastroenterology.

[6]  L. Bisanti,et al.  Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. , 2005, Journal of the National Cancer Institute.

[7]  H. Brenner,et al.  Should colorectal cancer screening start at the same age in European countries? Contributions from descriptive epidemiology , 2008, British Journal of Cancer.

[8]  O. Kronborg,et al.  Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds , 2004, Scandinavian journal of gastroenterology.

[9]  Jacques Ferlay,et al.  Cancer screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening. , 2008 .

[10]  H. Heard OC-116 Bowel screening wales—first round report , 2012, Gut.

[11]  A. Gossum,et al.  Le dépistage organisé du cancer colorectal en Communauté française de Belgique et surveillance des polypes. , 2009 .

[12]  N. Segnan,et al.  European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition – Principles of evidence assessment and methods for reaching recommendations , 2012, Endoscopy.

[13]  F. Johnson,et al.  Measuring patient preferences for colorectal cancer screening using a choice-format survey. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[14]  I. Sporea,et al.  To scope or to test for colorectal cancer screening? , 2013, Journal of gastrointestinal and liver diseases : JGLD.

[15]  A. Jemal,et al.  Worldwide Variations in Colorectal Cancer , 2009, CA: a cancer journal for clinicians.

[16]  M. Zorzi,et al.  Lo screening colorettale in Italia, survey 2010. , 2012 .

[17]  E. Ellerbeck,et al.  Disparities in colorectal cancer screening: a guideline-based analysis of adherence. , 2006, Ethnicity & disease.

[18]  H. Brenner,et al.  Expected reduction of colorectal cancer incidence within 8 years after introduction of the German screening colonoscopy programme: estimates based on 1,875,708 screening colonoscopies. , 2009, European journal of cancer.

[19]  Panos Kanavos,et al.  Colocteral cancer management and prevention policies in Greece , 2009, The European Journal of Health Economics.

[20]  Douglas K Rex,et al.  American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008 , 2022 .

[21]  Julietta Patnick,et al.  Colorectal cancer screening: A comparison of 35 initiatives in 17 countries , 2008, International journal of cancer.

[22]  T. Arulampalam,et al.  Screening for colorectal cancer: established and emerging modalities , 2011, Nature Reviews Gastroenterology &Hepatology.

[23]  Z. Tulassay,et al.  [The state of the colorectal screening in Hungary: lessons of the pilot programs]. , 2007, Orvosi hetilap.

[24]  L. Dušek,et al.  Colorectal cancer screening in Europe. , 2009, World journal of gastroenterology.

[25]  C. von Wagner,et al.  Uptake of colorectal cancer screening: system, provider and individual factors and strategies to improve participation. , 2009, Future oncology.

[26]  Michelle L. Klosterman,et al.  Adherence with colorectal cancer screening guidelines: a review. , 2004, Preventive medicine.

[27]  C. B. Steele,et al.  Colorectal cancer screening - United States, 2002, 2004, 2006, and 2008. , 2011, MMWR supplements.

[28]  E. Feuer,et al.  Impact of screening on incidence and mortality of prostate cancer in the United States. , 2001, Epidemiologic reviews.

[29]  Monika Ferlitsch,et al.  Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy. , 2011, JAMA.

[30]  L. Irwig,et al.  Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option , 2012, BMC Gastroenterology.

[31]  H. Brenner,et al.  Population-based prevalence estimates of history of colonoscopy or sigmoidoscopy: review and analysis of recent trends. , 2010, Gastrointestinal endoscopy.

[32]  Nancy Breen,et al.  Patterns of Colorectal Cancer Screening Uptake among Men and Women in the United States , 2006, Cancer Epidemiology Biomarkers & Prevention.

[33]  G. Ramsay,et al.  Impact of the Scottish Bowel Cancer Screening Programme on patient and tumour characteristics at a single centre. , 2014, Journal of evaluation in clinical practice.

[34]  R. Steele,et al.  Impact of the UK colorectal cancer screening pilot studies on incidence, stage distribution and mortality trends. , 2012, Cancer epidemiology.

[35]  Akshay Gupta,et al.  Early detection of colon cancer: new tests on the horizon. , 2008, Molecular diagnosis & therapy.

[36]  A. Neugut,et al.  Colonoscopy vs sigmoidoscopy screening: getting it right. , 2010, JAMA.

[37]  D. S̆timac,et al.  Results of National Colorectal Cancer Screening Program in Croatia (2007-2011). , 2012, World journal of gastroenterology.

[38]  R. Luckmann,et al.  Healthcare system factors and colorectal cancer screening. , 2002, American journal of preventive medicine.

[39]  L. Dušek,et al.  Czech National Cancer Screening Programmes in 2010. , 2010, Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti.

[40]  L. Holmberg,et al.  Toward understanding nonparticipation in sigmoidoscopy screening for colorectal cancer , 2007, International journal of cancer.

[41]  D. Parkin,et al.  The evolution of the population-based cancer registry , 2006, Nature Reviews Cancer.

[42]  D. Joseph,et al.  Prevalence of colorectal cancer screening among adults--Behavioral Risk Factor Surveillance System, United States, 2010. , 2012, MMWR supplements.

[43]  T. Church,et al.  The effect of fecal occult-blood screening on the incidence of colorectal cancer. , 2000, The New England journal of medicine.

[44]  O. Kronborg,et al.  A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds , 2002, Gut.

[45]  D. Nicolás-Pérez,et al.  Colorectal cancer screening in a Spanish population. , 2009, Medicina clinica.

[46]  Cancer,et al.  Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial , 2010, The Lancet.

[47]  S. Saini,et al.  Effect of Flexible Sigmoidoscopy-Based Screening on Incidence and Mortality of Colorectal Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2012, PLoS medicine.

[48]  L. Rabeneck,et al.  Association of Colonoscopy and Death From Colorectal Cancer , 2009, Annals of Internal Medicine.

[49]  A. Manning,et al.  Poor awareness of colorectal cancer symptoms; a preventable cause of emergency and late stage presentation , 2006, Irish journal of medical science.

[50]  M. Coleman,et al.  The state of the art of cancer control in 30 European countries in 2008 , 2010, International journal of cancer.

[51]  J. GarcíaSánchez [Colonoscopic polypectomy and long-term prevention of colorectal cancer deaths]. , 2012 .

[52]  J. Faivre,et al.  The cost-effectiveness of immunochemical tests for colorectal cancer screening. , 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[53]  I. Tountas,et al.  Screening programs for colorectal cancer in Greece: Results of two pilot studies conducted in March 2008 and 2009 , 2010 .

[54]  J Cuzick,et al.  Psychosocial influences on older adults' interest in participating in bowel cancer screening. , 2000, Preventive medicine.

[55]  R. Fletcher,et al.  Clinical Epidemiology: The Essentials , 1982 .

[56]  D. Nicolás-Pérez,et al.  Public awareness of colorectal cancer and screening in a Spanish population. , 2011, Public health.

[57]  H. Brenner,et al.  European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition – Evaluation and interpretation of screening outcomes , 2012, Endoscopy.

[58]  R. Pearson Association of Colonoscopy and Death from Colorectal Cancer , 2009 .

[59]  H. Brenner,et al.  Colorectal cancers occurring after colonoscopy with polyp detection: Sites of polyps and sites of cancers , 2013, International journal of cancer.

[60]  C. von Wagner,et al.  Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests , 2010, Gut.

[61]  S. Ciatto,et al.  Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence district , 2010, Gut.

[62]  U. Bauer,et al.  [Centers for Disease Control and Prevention (CDC)]. , 2000, Annales de dermatologie et de venereologie.

[63]  L. Guittet,et al.  Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population , 2006, Gut.

[64]  J. V Schönfeld [Colonoscopy versus fecal immunochemical testing in colorectal cancer screening]. , 2013, Zeitschrift fur Gastroenterologie.

[65]  G S Gazelle,et al.  Screening for colorectal cancer. , 2000, Radiology.

[66]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[67]  Carlos Gouveia Pinto,et al.  Colorectal cancer in Portugal , 2009, The European Journal of Health Economics.

[68]  J. Waterhouse Cancer incidence in five continents, v.3 , 1976 .

[69]  M. Zorzi,et al.  Screening for colorectal cancer in Italy: 2011-2012 survey. , 2015, Epidemiologia e prevenzione.

[70]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.

[71]  N. Kieffer,et al.  Colon cancer in Luxembourg: a national population-based data report, 1988–1998 , 2003, BMC Cancer.

[72]  Y. Eishi,et al.  Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening , 2010, Journal of Gastroenterology.

[73]  S. Ciatto,et al.  Cancer screening in the European Union. , 1994, European journal of cancer.

[74]  E. Kuipers,et al.  Risk analyses for screening sigmoidoscopy based on a colorectal cancer (CRC) population , 2009, Scandinavian journal of gastroenterology.

[75]  O. Lantieri,et al.  Colorectal cancer screening: why immunochemical faecal occult blood test performs as well with either one or two samples. , 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[76]  H. Brenner,et al.  Utilization of lower gastrointestinal endoscopy and fecal occult blood test in 11 European countries: evidence from the Survey of Health, Aging and Retirement in Europe (SHARE) , 2010, Endoscopy.

[77]  E. Haglind,et al.  Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer , 2008, The British journal of surgery.

[78]  T. Church,et al.  Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. , 1999, Journal of the National Cancer Institute.

[79]  B. Larsen [Colorectal cancer screening]. , 2010, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[80]  J. Mossong,et al.  Colorectal cancer incidence is low in patients following a colonoscopy. , 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[81]  S. Woolf,et al.  The relative importance of patient-reported barriers to colorectal cancer screening. , 2010, American journal of preventive medicine.

[82]  T. Stukel,et al.  Association Between Colonoscopy Rates and Colorectal Cancer Mortality , 2010, The American Journal of Gastroenterology.

[83]  J. Wardle,et al.  Marriage and cancer prevention: Does marital status and inviting both spouses together influence colorectal cancer screening participation? , 2006, Journal of medical screening.

[84]  Louis H. Primavera,et al.  Adherence to Colorectal Cancer Screening in Mammography-Adherent Older Women , 2003, Journal of Behavioral Medicine.

[85]  L. Döbrőssy,et al.  National cancer screening programme in Hungary , 2011 .

[86]  A. Zauber,et al.  Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. , 2012, The New England journal of medicine.

[87]  J. Borrás,et al.  False-positive results from colorectal cancer screening in Catalonia (Spain), 2000–2010 , 2012, Journal of medical screening.

[88]  E. Loftus,et al.  Risk of colorectal cancer after colonoscopy compared with flexible sigmoidoscopy or no lower endoscopy among older patients in the United States, 1998-2005. , 2013, Mayo Clinic proceedings.

[89]  A. García Factors influencing colorectal cancer screening participation , 2012 .

[90]  Kovárová Jt [Colorectal screening program--participation of general gynecologists]. , 2011 .

[91]  J. Ferlay,et al.  Fifty years of cancer incidence: CI5 I–IX , 2010, International journal of cancer.

[92]  K. Guire,et al.  Colorectal cancer screening attitudes and behavior: a population-based study. , 2003, Preventive medicine.

[93]  I. Vejborg,et al.  Overdiagnosis in screening mammography in Denmark: population based cohort study , 2013, BMJ : British Medical Journal.

[94]  M. Muñoz-Navas,et al.  Prevention or cure in times of crisis: the case of screening for colorectal cancer. , 2012, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[95]  Robert A. Smith,et al.  Toward standardizing and reporting colorectal cancer screening indicators on an international level: The international colorectal cancer screening network , 2012, International journal of cancer.

[96]  S. Moss,et al.  Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial , 2002, Gut.

[97]  M. Muñoz-Navas,et al.  Prevenir o curar en época de crisis: a propósito del cribado de cáncer de colon y recto , 2012 .

[98]  A. Verbeek,et al.  Comparison of Guaiac and Immunochemical Fecal Occult Blood ests for Colorectal Cancer in a Screening Population , 2022 .

[99]  S. Coughlin,et al.  Colorectal cancer screening practices among men and women in rural and nonrural areas of the United States, 1999. , 2004, The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association.

[100]  R. Steele,et al.  Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study. , 2006, The Lancet. Oncology.

[101]  H. Comber,et al.  Using resource modelling to inform decision making and service planning: the case of colorectal cancer screening in Ireland , 2013, BMC Health Services Research.